Polatuzumab Vedotin With R-CHP Shows Strong Activity in Older DLBCL Patients

(MedPage Today) — At the recent American Society of Hematology (ASH) annual meeting, a multicenter retrospective analysis used real-world data to examine the use of polatuzumab vedotin (Polivy) with rituximab, cyclophosphamide, doxorubicin, prednisone…

Source link : https://www.medpagetoday.com/meetingcoverage/ashfuturefocusdlbcl/118911

Author :

Publish date : 2025-12-09 17:52:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Polatuzumab Vedotin With R-CHP Shows Strong Activity in Older DLBCL Patients

PA- and Physician-Led Heart Transplant Recovery Comparable

2025 was chock full of exciting discoveries in human evolution

Related Posts

‘I needed a coil to ease the bleeding but I just sat on a waiting list’

Telesurgery Shows Promise for Radical Prostatectomy, Partial Nephrectomy

CMS Makes Push to Maximize Donor Organs, Even the Imperfect Ones

Ending Animal Research Won’t Make America Healthy

RFK Jr. Names 21 New Members to Federal Autism Committee

Gun Injuries in Parents Linked to Mental Health Issues in Kids

‘I needed a coil to ease the bleeding but I just sat on a waiting list’

Telesurgery Shows Promise for Radical Prostatectomy, Partial Nephrectomy

CMS Makes Push to Maximize Donor Organs, Even the Imperfect Ones

Ending Animal Research Won’t Make America Healthy

RFK Jr. Names 21 New Members to Federal Autism Committee

Gun Injuries in Parents Linked to Mental Health Issues in Kids

Psoriatic Disease: QOL Improved With GLP-1 RA Plus Biologic

New Stroke Guideline Pushes EVT for Larger Core Strokes, Mobile Stroke Units

Categories

Archives